1. Update on transfusion-related acute lung injury: an overview of its pathogenesis and management
   Yunhong Yu et al, 2023, Frontiers in Immunology CrossRef
2. Mechanism of CAV and CAVIN Family Genes in Acute Lung Injury based on DeepGENE
   Jingyu Huang et al, 2023, Current Gene Therapy CrossRef
3. Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C
   null Sandeep et al, 2024, Molecular Neurobiology CrossRef
4. Platelets play a dual role in the pathophysiology of transfusion-related acute lung injury
   Liqin Ling et al, 2023, Respiratory Physiology & Neurobiology CrossRef
5. Postoperative hypoxemia for patients undergoing Stanford type A aortic dissection
   Hai-Yuan Liu et al, 2023, World Journal of Clinical Cases CrossRef
6. Preservation of recipient plasma sphingosine-1-phosphate levels reduces transfusion-related acute lung injury
   Vanessa Hsing et al, 2024, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
7. Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies
   Da-Wei Chen et al, 2023, JCI Insight CrossRef
8. Plasma Proteomics-Based Discovery of Mechanistic Biomarkers of Hyperbaric Stress and Pulmonary Oxygen Toxicity
   Kyle J. Mahoney et al, 2023, Metabolites CrossRef
9. JMJD3 deficiency alleviates lipopolysaccharide‑induced acute lung injury by inhibiting alveolar epithelial ferroptosis in a Nrf2‑dependent manner
   Junwei Peng et al, 2021, Molecular Medicine Reports CrossRef
10. Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions
    John-Paul Tung et al, 2022, Blood Reviews CrossRef